1998
Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey.
Coffin C, Humphrey P, Dehner L. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Seminars In Diagnostic Pathology 1998, 15: 85-101. PMID: 9606801.Peer-Reviewed Original ResearchConceptsInflammatory myofibroblastic tumorExtrapulmonary sitesAberrant inflammatory responseSoft tissue mesenchymal tumorsLow malignant potentialEpstein-Barr virusSpindle cell sarcomaSpindle cell neoplasmConstitutional symptomsInflammatory hypothesisInflammatory pseudotumorSurgical resectionInflammatory natureLocal recurrenceMyofibroblastic tumorPrognostic categoriesVascular invasionCell sarcomaPathological featuresMalignant potentialInflammatory processPathological diagnosisInflammatory responseCell neoplasmsEmbryonal rhabdomyosarcoma
1993
Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical Prostatectomy
Frazier H, Robertson J, Humphrey P, Paulson D. Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical Prostatectomy. Journal Of Urology 1993, 149: 516-518. PMID: 7679755, DOI: 10.1016/s0022-5347(17)36132-3.Peer-Reviewed Original ResearchConceptsProstate-specific antigenPostoperative serum PSA levelsSerum PSA levelsPSA levelsPSA elevationSpecific antigenPostoperative prostate-specific antigenSerum prostate-specific antigenPostoperative PSA levelMargin-positive diseaseRadical perineal prostatectomySerum acid phosphatasePositive diseaseBone scanCurative therapyLocal recurrenceTreatment courseRadical prostatectomyMalignant diseasePerineal prostatectomyClinical failureProstate cancerPositive groupPatientsClinical importance